Endnotes
1. “Effects of Vaccination on the Endocrine and Immune Systems of Dogs, Phase II”, Purdue University, November 1,1999, at
haywardstudyonvaccines.
2. See
www.vet.purdue.edu/epi/gdhstudy.htm.
3. See
Vaccine Associated Feline Sarcoma Task Force (VAFSTF) Home Page.
4. Veterinary Products Committee (VPC) Working Group on Feline and Canine Vaccination, DEFRA, May 2001.
5. JVM Series A 50(6):286-291, August 2003.
6. Duval, D. and Giger,U. (1996). “Vaccine-Associated Immune-Mediated Hemolytic Anemia in the Dog”, Journal of Veterinary Internal Medicine 10:290-295.
7. New England Journal of Medicine, vol.313,1985.
See also Clin Exp Rheumatol 20(6):767-71, Nov-Dec 2002.
8. Am Coll Vet Intern Med 14:381,2000.
9. Dodds, Jean W.,DVM, “Immune System and Disease Resistance”, at
Immune System - Dr. Jean Dodds.
10. Wolf Clan magazine, April/May 1995.
11. Goldstein, Martin, The Nature of Animal Healing, Borzoi/Alfred A. Knopf, Inc., 1999.
12. Wolf Clan magazine, op. cit.
13. ibid.
14. Journal of Inflammation 1:3,2004, at
Journal of Inflammation content/1/1/3.
15. Klingborg, D.J., Hustead, D.R. and Curry-Galvin, E. et al., “AVMA Council on Biologic and Therapeutic Agents’ report on cat and dog vaccines”, Journal of the American Veterinary Medical Association 221(10):1401-1407, November 15,2002,
http://www.avma.org/policies/vaccination.htm.
16. ibid.
17. Schultz, R.D., “Current and future canine and feline vaccination programs”, Vet Med 93:233-254,1998.
18. Schultz, R.D., Ford, R.B., Olsen, J. and Scott, P., “Titer testing and vaccination: a new look at traditional practices”, Vet Med 97:1-13, 2002 (insert).
19. Twark, L. and Dodds, W.J., “Clinical application of serum parvovirus and distemper virus antibody liters for determining revaccination strategies in healthy dogs”, J Am Vet Med Assoc 217:1021-1024,2000.